A Pilot Study Investigating the Use of a Therapeutic Wand in Addition to

Status Completed

Clinical Trial Summary

Bladder pain syndrome is a condition where pain is experienced when the bladder fills with urine and eases briefly when the bladder empties. There can also be a constant need to urgently empty the bladder.

The internal pelvic floor muscles in people with bladder pain syndrome can be tense and painful, and relaxing and stretching them may improve symptoms; reducing bladder pain, urgency and how often people have to empty their bladder.

This pelvic floor release is done by specialist physiotherapists.Therapeutic wands, such as the TheraWand®, are used routinely throughout the United Kingdom to allow people to relax and stretch their pelvic floor themselves. Using a therapeutic wand has been shown to be safe and to reduce pelvic pain, improve bladder and bowel symptoms and relax the pelvic floor muscles. However, this research was conducted mostly in men with pelvic pain.

The aim of this study is to find out if using a therapeutic wand at home as well as having a specialist physiotherapist massage the pelvic floor gives any added benefit than just having the physiotherapy treatment. The investigators hope to find out if the therapeutic wand gives women a way of managing their symptoms independently in their own homes.

Clinical Trial Description

A volunteer sample of ten women will be recruited and randomised into two groups, with descriptive analysis of their demographics at baseline. Both groups will receive six weeks of standard pelvic floor myofascial release by a specialist physiotherapist and one group will also use a therapeutic wand twice weekly at home. Outcome measures of bladder urgency, pain, health related quality of life and the perceived effect and ease of therapeutic wand use will be measured weekly for six weeks of treatment and then six weeks following treatment. A diary of therapeutic wand use, release exercises and medication use will also be kept for 3 months. Analysis of any significant difference in symptom change between the two groups and of subjective ease of wand use will then occur and inform the development of a randomised controlled trial. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02743962
Study type	Interventional
Source	University of Bradford
Contact
Status	Completed
Phase	N/A
Start date	April 2016
Completion date	October 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04313972` - IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone	Phase 4
Recruiting	`NCT02868775` - A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome	N/A
Not yet recruiting	`NCT01410461` - Identifying Predictors of Treatment Success in Painful Bladder Syndrome	N/A
Completed	`NCT01197261` - OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)	Phase 2
Completed	`NCT00150488` - URACYST® For the Treatment of GAG Deficient Interstitial Cystitis	N/A
Completed	`NCT00672087` - Diagnostic Challenges in IC (and Male CPPS)
Completed	`NCT02232282` - Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial	N/A
Completed	`NCT00775281` - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC.	N/A
Completed	`NCT05223244` - Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC	Phase 4
Completed	`NCT02600715` - Reduction of Bladder Injection Pain With Belladonna Opiate Suppository	Phase 4
Completed	`NCT02457182` - Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome	N/A
Withdrawn	`NCT03027076` - Microbiome of Urologic Chronic Pelvic Pain Syndrome	N/A
Completed	`NCT00434343` - Physical Therapy Trial for Pelvic Pain	N/A
Terminated	`NCT03143920` - Hyperbaric Oxygen Therapy for Inflammatory Conditions of the Urinary Bladder	Early Phase 1
Completed	`NCT02411110` - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome	Phase 2
Completed	`NCT00903643` - Sensory Processing in Subjects With Painful Bladder Syndrome	N/A
Completed	`NCT00194610` - Botox as a Treatment for Interstitial Cystitis in Women	Phase 4
Recruiting	`NCT06299683` - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment	N/A
Terminated	`NCT04268810` - Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis	Phase 4
Completed	`NCT01294878` - Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Pilot Study Investigating the Use of a Therapeutic Wand in Addition to Physiotherapy for Bladder Pain Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms